首页> 外文OA文献 >A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from the processing of allogeneic human somatic stem cells

【2h】

A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from the processing of allogeneic human somatic stem cells

机译：确保同种异体人体干细胞加工产生的药品和医疗器械的质量和安全性的研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hayakawa Takao; Aoi Takashi; Umezawa Akihiro; Ozawa Keiya; Sato Yoji; Sawa Yoshiki; Matsuyama Akifumi; Yamanaka Shinya; Yamato Masayuki;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from the processing of allogeneic human somatic stem cells [J] . Takao Hayakawa, Takashi Aoi, Akihiro Umezawa, Regenerative Therapy . 2015,第6期

机译：确保同种异体人体干细胞加工产生的药品和医疗器械的质量和安全性的研究
2. A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from processing of allogeneic human induced pluripotent stem(-Like) cells [J] . Takao Hayakawa, Takashi Aoi, Akihiro Umezawa, Regenerative Therapy . 2015,第6期

机译：确保同种异体人诱导多能干（-Like）细胞加工产生的药品和医疗器械的质量和安全性的研究
3. A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from the processing of autologous human somatic stem cells [J] . Takao Hayakawa, Takashi Aoi, Akihiro Umezawa, Regenerative Therapy . 2015,第6期

机译：确保自体人类体干细胞加工产生的药品和医疗器械的质量和安全性的研究
4. Case Study: Application of a Systematic Quality Improvement Methodology to a Medical Device Safety Alerts Process [C] . Brendan P. Gribbons, Laura E. Yong Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2020

机译：案例研究：系统质量改进方法在医疗设备安全警报过程中的应用
5. Regulation of Novel biomedical Technologies: 1. On Presidents, Agencies and the Stem Cells Between Them: A Legal Analysis of President Bush's and the Federal Government's Policy on the Funding of Research Involving Human Embryonic Stem Cells 2. The Regulation of the Genetic Aspects of Donated Reproductive Tissue: The Need for Federal Regulation 3. Patents Versus Statutory Exclusivities in Biological Pharmaceuticals---Do We Really Need Both? [D] . Heled, Yaniv. 2011

机译：新型生物医学技术的法规：1.关于总统，机构及其之间的干细胞：对布什总统和联邦政府关于人类胚胎干细胞研究资助政策的法律分析2.捐赠的遗传方面的法规生殖组织：联邦法规的必要性3.生物药品中的专利权与法定专有权-我们真的需要两者吗？
6. A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from the processing of allogeneic human somatic stem cells [O] . Takao Hayakawa, Takashi Aoi, Akihiro Umezawa, 2015

机译：确保同种异体人体干细胞加工产生的药品和医疗器械的质量和安全性的研究
7. A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from processing of allogeneic human induced pluripotent stem(-Like) cells [O] . Hayakawa Takao, Aoi Takashi, Umezawa Akihiro, 2015

机译：确保同种异体人诱导多能干（-Like）细胞加工产生的药品和医疗器械的质量和安全性的研究

A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from the processing of allogeneic human somatic stem cells

著录项

引文网络

相似文献

相关主题

期刊订阅